新疆医科大学第一附属医院创伤骨科,新疆 乌鲁木齐 830054
Received:12 August 2025,
Published:25 May 2026
移动端阅览
吴秀凯,杜彩梅,麻俊超等.吲哚胺2,3-双加氧酶1上调促进骨包虫组织浸润和免疫逃逸的机制研究[J].局解手术学杂志,2026,35(05):421-427.
WU Xiu-kai,DU Cai-mei,MA Jun-chao,et al.Mechanism of upregulated indoleamine 2,3-dioxygenase 1 in promoting tissue infiltration and immune evasion of bone hydatid disease[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2026,35(05):421-427.
吴秀凯,杜彩梅,麻俊超等.吲哚胺2,3-双加氧酶1上调促进骨包虫组织浸润和免疫逃逸的机制研究[J].局解手术学杂志,2026,35(05):421-427. DOI: 10.11659/jjssx.08E025055.
WU Xiu-kai,DU Cai-mei,MA Jun-chao,et al.Mechanism of upregulated indoleamine 2,3-dioxygenase 1 in promoting tissue infiltration and immune evasion of bone hydatid disease[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2026,35(05):421-427. DOI: 10.11659/jjssx.08E025055.
目的
2
探讨吲哚胺2,3-双加氧酶1(IDO1)上调促进骨包虫病(BHD)组织浸润和免疫逃逸的分子机制。
方法
2
免疫荧光染色检测手术切除的BHD囊肿组织和膝关节骨关节炎(OA)组织中M2表型巨噬细胞表面标志物CD206和CD163的表达以及IDO1的表达。
Pearson
相关系数法分析BHD组织中每视野下CD206
+
CD163
+
巨噬细胞和IDO1
+
细胞数量的相关性。体外培养人单核细胞白血病细胞系THP1,诱导THP1细胞向M2表型极化,并在诱导处理中添加包虫抗原B(EgB)。细胞分组1:Control组、EgB处理组,CCK-8法测定各组细胞增殖能力。细胞分组2:M0诱导-Control组、M1诱导-Control组、M2诱导-Control组、M0诱导-EgB处理组、M1诱导-EgB处理组、M2诱导-EgB处理组,使用RT-qPCR法测定CD68、F4/80、转化生长因子β1(TGF-β1)、CD86和CD163 mRNA的表达水平;Western blot检测M2诱导-Control组、M2诱导-EgB处理组细胞中IDO1和TGF-β1蛋白表达。细胞分组3:M2诱导-Control组、M2诱导-EgB处理组、M2诱导-EgB+shRNA-IDO1组、M2诱导-EgB+shRNA-NT组、M2诱导-EgB+OE-IDO1组、M2诱导-EgB+vector组,RT-qPCR法测定细胞中CD68和CD163 mRNA的表达水平,Western blot检测细胞中IDO1、TGF-β1、细胞程序性死亡蛋白-1(PD-1)、磷酸肌醇3-激酶(PI3K)、p-PI3K、蛋白激酶B(Akt)、p-Akt、哺乳动物雷帕霉素靶蛋白(mTOR)和p-mTOR表达。
结果
2
与OA组织相比,BHD组织中每视野下IDO1
+
细胞数、CD206
+
CD163
+
巨噬细胞数显著增加(
P
0.05)。
Pearson
相关系数法分析结果显示,每视野下IDO1
+
细胞数与该视野下CD206
+
CD163
+
巨噬细胞数呈正相关(
r
=0.933 1,
P
0.01)。与Control组相比,EgB处理组THP1细胞增殖能力增强(
P
0.01)。与M0诱导-Control组相比,M0诱导-EgB处理组M0表型极化标志物CD68和F4/80 mRNA表达水平升高(
P
0.01);与M2诱导-Control组相比,M2诱导-EgB处理组M2表型极化标志物CD68和CD163
mRNA表达水平升高(
P
0.01);M1诱导-Control组和M1诱导-EgB处理组TNF-α和CD86 mRNA表达水平无统计差异(
P
0.05)。与M2诱导-Control组相比,M2诱导-EgB处理组IDO1、TGF-β1、PD-1蛋白表达水平,p-PI3K/PI3K、p-Akt/Akt、p-mTOR/mTOR水平均升高(
P
0.05)。与M2诱导-EgB处理组相比,M2诱导-EgB+shRNA-IDO1组CD68和CD163 mRNA表达水平,IDO1、TGF-β1、PD-1蛋白表达水平,p-PI3K/PI3K、p-Akt/Akt、p-mTOR/mTOR水平均降低(
P
0.05);M2诱导-EgB+OE-IDO1组CD68和CD163 mRNA表达水平,IDO1、TGF-β1、PD-1蛋白表达水平,p-PI3K/PI3K、p-Akt/Akt、p-mTOR/mTOR水平均升高(
P
0.05)。
结论
2
EgB能够增强IDO1的表达,刺激巨噬细胞向M2表型极化并激活TGF-β1、PD-1、PI3K/Akt/mTOR等信号通路,介导形成骨包虫感染时的免疫抑制微环境。
Objective
2
To explore the molecular mechanisms of upregulated indoleamine 2,3-dioxygenase 1 (IDO1) in promoting tissue infiltration and immune evasion of bone hydatid disease (BHD).
Methods
2
Immunofluorescence staining was used to detect the expression of surface markers CD206 and CD163 on M2 phenotype macrophages, as well as IDO1 expression in the surgically resected BHD cyst tissues and knee osteoarthritis (OA) tissues.
Pearson
correlation analysis was conducted to analyze the correlation between the number of CD206
+
CD163
+
macrophages and IDO1
+
cells per visual field in BHD tissues. The human monocyte leukemia cell line THP1 was cultured in vitro. THP1 cells were induced to polarize towards the M2 phenotype, and the hydatid cyst fluid native antigen B (EgB) was added during the induction process. For cell experiment Group 1, cells were divided into the Control group, the EgB-treated group. CCK-8 assay was used to detect the cell proliferation ability. For cell experiment Group 2, cells were divided into the M0-induced-Control group, the M1-induced-Control group, the M2-induced-Control group, the M0-induced-EgB-treated group, the M1-induced-EgB-treated group, and the M2-induced-EgB-treated group. RT-qPCR was used to detect the mRNA expression l
evels of CD68, F4/80, transforming growth factor-β1 (TGF-β1), CD86, and CD163. Western blot was used to detect the protein expression levels of IDO1 and TGF-β1 in the M2-induced-Control group and the M2-induced-EgB-treated group. For cell experiment Group 3, cells were divided into the M2-induced-Control group, the M2-induced-EgB-treated group, the M2-induced-EgB+shRNA-IDO1 group, the M2-induced-EgB+shRNA-NT group, the M2-induced-EgB+OE-IDO1 group, and the M2-induced-EgB+vector group. RT-qPCR was used to detect the mRNA expression levels of CD68 and CD163 in cells. Western blot was used to detect the expression levels of IDO1, TGF-β1, programmed cell death protein 1 (PD-1), phosphoinositol 3-kinase (PI3K),p-PI3K, protein kinase B(Akt), p-Akt, mammalian target of rapamycin(mTOR) and p-mTORin cells.
Results
2
Compared with OA tissues, the numbers of IDO1
+
cells and CD206
+
CD163
+
macrophages per visual field in BHD tissues were significantly increased (
P
0.05).
Pearson
correlation analysis results showed that the number of IDO1
+
cells per visual field was positively correlated with the number of CD206
+
CD163
+
macrophages per visual field (
r
=0.933 1,
P
0.01). Compared with the Control group, the proliferation ability of THP1 cells in the EgB-treated group was enhanced (
P
0.01). Compared with the M0-induced-Control group, the mRNA expression levels of M0 phenotype polarization markers CD68 and F4/80 in the M0-induced-EgB-treated group were increased (
P
0.01). Compared with the M2-induced-Control group, the mRNA expression levels of M2 phenotype polarization markers CD68 and CD163 in the M2-induced-EgB-treated group were increased (
P
0.01). There was no statistically significant difference in the mRNA expression levels of TNF-α and CD86 between the M1-induced-Control group and the M1-induced-EgB-treated group (
P
0.05). Compared with the M2-induced-Control group, the protein expression levels of IDO1, TGF-β1, and PD-1, as well as the ratios of p-PI3K/PI3K, p-Akt/Akt, and p-mTOR/mTOR in the M2-induced-EgB-treated group were increased (
P
0.05). Compared with the M2-induced-EgB-treated group, the mRNA expression levels of CD68 and CD163, the protein expression levels of IDO1, TGF-β1, and PD-1, and the ratios of p-PI3K/PI3K, p-Akt/Akt, and p-mTOR/mTOR in the M2-induced-EgB+shRNA-IDO1 group were all decreased (
P
0.05); while the mRNA expression levels of CD68 and CD163, the protein expression levels of IDO1, TGF-β1, and PD-1, and the ratios of p-PI3K/PI3K, p-Akt/Akt, and p-mTOR/mTOR in the M2-induced-EgB+OE-IDO1 group were all increased (
P
0.05).
Conclusion
2
EgB can enhance the expression of IDO1 to stimulate the polarization of macrophages toward the M2 phenotype, and activate the TGF-β1, PD-1, PI3K/Akt/mTOR signaling pathways, thereby mediating the formation of immunosuppressive microenvironment during bone echinococcosis infection.
Monge-Maillo B , Lopez-Velez R . Cystic echinococcosis of the bone [J]. Curr Opin Infect Dis , 2023 , 36 ( 5 ): 341 - 347 . doi: 10.1097/QCO.0000000000000951 http://dx.doi.org/10.1097/QCO.0000000000000951 .
Ammar A , Riahi H , Chaabouni M , et al . The multifaceted musculoskeletal hydatid disease [J]. Skeletal Radiol , 2024 , 53 ( 10 ): 2181 - 2194 . doi: 10.1007/s00256-024-04644-0 http://dx.doi.org/10.1007/s00256-024-04644-0 .
常玉山 , 杨来红 , 何雄 , 等 . 骨包虫病的影像学表现 [J]. 中国CT和MRI杂志 , 2023 , 21 ( 12 ): 172 - 174 . doi: 10.3969/j.issn.1672-5131.2023.12.053 http://dx.doi.org/10.3969/j.issn.1672-5131.2023.12.053 .
吾路汗·马汗 , 谢增如 . 白细胞介素-9诱导破骨细胞分化在包虫病骨侵蚀中的机制研究 [J]. 局解手术学杂志 , 2025 , 34 ( 6 ): 489 - 493 . doi: 10.11659/jjssx.03E024159 http://dx.doi.org/10.11659/jjssx.03E024159 .
Sun Y , Yan C , Tian D , et al . Imaging manifestations and misdiagnosis analysis of six cases of bone hydatid disease [J]. Korean J Parasitol , 2022 , 60 ( 6 ): 413 - 417 . doi: 10.3347/kjp.2022.60.6.413 http://dx.doi.org/10.3347/kjp.2022.60.6.413 .
Zhao Y , Zhang B , Zhang Q , et al . Tumor-associated macrophages in osteosarcoma [J]. J Zhejiang Univ Sci B , 2021 , 22 ( 11 ): 885 - 892 . doi: 10.1631/jzus.B2100029 http://dx.doi.org/10.1631/jzus.B2100029 .
Toda Y , Kohashi K , Yamada Y , et al . PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients:comparative study of primary and metastatic lesions [J]. J Cancer Res Clin Oncol , 2020 , 146 ( 10 ): 2607 - 2620 . doi: 10.1007/s00432-020-03242-6 http://dx.doi.org/10.1007/s00432-020-03242-6 .
Cai Z , Li W , Hager S , et al . Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling [J]. Cell Mol Immunol , 2024 , 21 ( 5 ): 448 - 465 . doi: 10.1038/s41423-024-01134-0 http://dx.doi.org/10.1038/s41423-024-01134-0 .
吾路汗·马汗 , 谢增如 . 包虫抗原B通过抑制TAZ促进RANKL/ NF-κB/TAK1介导的破骨细胞发生 [J]. 医学分子生物学杂志 , 2025 , 22 ( 1 ): 8 - 15 . doi: 10.3870/j.issn.1672-8009.2025.01.002 http://dx.doi.org/10.3870/j.issn.1672-8009.2025.01.002 .
Meng Y , Ren Q , Xiao J , et al . Progress of research on the diagnosis and treatment of bone cystic echinococcosis [J]. Front Microbiol , 2023 , 14 : 1273870 . doi: 10.3389/fmicb.2023.1273870 http://dx.doi.org/10.3389/fmicb.2023.1273870 .
Liu W , Li L , Bai X , et al . Osteosarcoma cell-derived migrasomes promote macrophage M2 polarization to aggravate osteosarcoma proliferation and metastasis [J]. Adv Sci (Weinh) , 2025 , 12 ( 17 ): e2409870 . doi: 10.1002/advs.202409870 http://dx.doi.org/10.1002/advs.202409870 .
陈华敏 , 何志军 , 涂伟 , 等 . M2型肿瘤相关巨噬细胞参与胃癌细胞转移及免疫逃逸的机制研究 [J]. 局解手术学杂志 , 2023 , 32 ( 9 ): 771 - 777 . doi: 10.11659/jjssx.07E022106 http://dx.doi.org/10.11659/jjssx.07E022106 .
Wang L , Li S , Luo H , et al . PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages [J]. J Exp Clin Cancer Res , 2022 , 41 ( 1 ): 303 . doi: 10.1186/s13046-022-02477-0 http://dx.doi.org/10.1186/s13046-022-02477-0 .
Su P , Jiang L , Zhang Y , et al . Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5/PI3K/AKT/mTOR pathway in gastric cancer [J]. Cancer Cell Int , 2022 , 22 ( 1 ): 290 . doi: 10.1186/s12935-022-02717-5 http://dx.doi.org/10.1186/s12935-022-02717-5 .
Xie L , Chen C , Liang X , et al . Expression and clinical significance of various checkpoint molecules in advanced osteosarcoma:possibilities for novel immunotherapy [J]. Orthop Surg , 2023 , 15 ( 3 ): 829 - 838 . doi: 10.1111/os.13620 http://dx.doi.org/10.1111/os.13620 .
Liang X , Gao H , Xiao J , et al . Abrine,an IDO1 inhibitor,suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma [J]. Front Immunol , 2023 , 14 : 1185985 . doi: 10.3389/fimmu.2023.1185985 http://dx.doi.org/10.3389/fimmu.2023.1185985 .
0
Views
4
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
